Naveed Saleh, MD, MS | Authors

Alpelisib Is Changing the Clinical Landscape in Breast Cancer Treatment

November 14, 2019

The US Food and Drug Administration recently approved alpelisib plus fulvestrant for the treatment of metastatic or otherwise advanced breast cancer.

Immunotherapy Advances: 2019

October 28, 2019

This year has seen many advances in immunotherapy. Here is a look at some of the most significant research.